SYNAPS Dx is pleased to announce our membership with the American Brain Coalition (ABC), a nonprofit organization comprising many of the United States’ leading patient advocacy and voluntary health organizations, as well as professional neurological, psychological and psychiatric associations.
With our focus on early diagnosis of Alzheimer’s Disease (AD), our team looks forward to advancing research on functions of the brain and reducing the burden of brain disorders through public education and advocacy.
With an established presence in Washington, ABC is a strong and powerful voice for the 100 million people living with disabling brain disorders, bringing together organizations that represent concerned and interested patients, families and professionals.
We want to play role in serving as advocates for increased support of research that leads to better treatment, services and support that improves patients’ quality of life and a national commitment towards finding cures for individuals with neurological and psychiatric disorders.
We’re proud to be members of ABC and to join the coalition’s education and advocacy initiatives.
A key component of improving the lives of those living with dementia is supporting a definitive diagnosis. We offer DISCERN™, a minimally invasive skin test to accurately assess if dementia symptoms are AD or another, possibly curable condition—informing clinician care plans while giving families greater peace of mind.
To learn more visit here.